Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
307.4 USD | +0.05% | +3.71% | +6.72% |
Jun. 05 | Amgen Says Phase 3 Trial of Potential Autoimmune Disease Treatment Meets Endpoints | MT |
Jun. 05 | Amgen's Uplizna Hits Phase 3 Endpoints in IgG4-RD | DJ |
- Stock Market
- Equities
- AMGN Stock
- News Amgen Inc.
- Other languages